Article Text

Crohn’s disease: why the disparity in mortality?
  1. E V Loftus Jr
  1. Correspondence to:
    Dr E V Loftus Jr
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street, SW Rochester, MN 55905, USA; loftus.edward{at}

Statistics from

There has been no significant decrease in mortality in patients with Crohn’s disease over the last several decades

It is well accepted that Crohn’s disease is associated with a small but real risk of death. Population based reports from Sweden,1,2 Denmark,3 and Italy4 indicate that Crohn’s disease patients have a higher mortality rate than expected, although at least one notable exception from the UK demonstrated survival similar to the general population (table 1).5 A preliminary report from Olmsted County, Minnesota, indicated a mortality rate that was about 20% higher (but not significantly different statistically) than that expected,6 standing in contrast with the results of a previous report from the same location.7 The largest study of mortality in Crohn’s disease was from a cohort of approximately 6000 patients identified through the General Practice Research Database (GPRD), which contains the computerised medical records of 6% of the British population.8 The annual mortality rate in Crohn’s disease was 1.6% compared with 1.0% in age, sex, and practice matched controls. After adjusting for age, sex, and cigarette smoking, it appeared that the risk of death was 73% higher in Crohn’s disease patients than in controls.8 Although the large cohort size makes this study important, its generalisability is limited by the fact that the cohort was a mixture of incidence and prevalence cases, the average age at entry into the cohort was 42 years (higher than the average age at diagnosis of Crohn’s disease of late 20s/early 30s in most studies), and the average follow up was only three years. A recent systematic review of “hard end points” in population based cohorts of Crohn’s disease concluded that there was no evidence for a significant change in disease outcome over the past 40 years.9 To summarise, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.